Partnership : Academics = 
, Industrials = 
, Financial investitors = 
-
- BELGIUM
- VLAAMS BRABANT
- LEUVEN
- Translational research on the role of ephrin system in the pathogenesis of amyotrophic lateral sclerosis
- University Hospitals Leuven - Gasthuisberg
- NMRC UZLeuven
- More details
-
- MRI biomarkers in ALS
- University of Alberta
- Department of Medicine, Division of Neurology
- More details
-
- CANADA
- Colombie-Britannique
- VANCOUVER
- FORGE - Finding of Rare Disease Genes in Canada
- University of British Columbia
- Faculty of Medicine
- More details
-
- CANADA
- Ontario
- OTTAWA, ONTARIO
- FORGE - Finding of Rare Disease Genes in Canada
- University of Ottawa
- Faculty of Medicine -
- More details
-
- FORGE - Finding of Rare Disease Genes in Canada
- Centre hospitalier universitaire Sainte-Justine
- Pédiatrie
- More details
-
- Mitofaagia roll neurodegeneratiivsete haiguste korral
- University of Tartu
- Centre of molecular and clinical medicine
- More details
-
- Study of expressivity of Nogo gene and reticulons in ALS patients musculus skeleti
- Faculté de médecine de Strasbourg - Louis Pasteur
- Laboratoire de signalisations moléculaires et neurodégénérescence
- More details
-
- Involvement of metabolic dysfunctions in the pathogenesis of amyotrophic lateral sclerosis
- Faculté de médecine de Strasbourg - Louis Pasteur
- Laboratoire de signalisations moléculaires et neurodégénérescence
- More details
-
- FRANCE
- AUVERGNE
- CLERMONT-FERRAND
- Study of Mitochondrial Functions and Oxidative Stress in ALS Patients
- CHU de Clermont-Ferrand - Hôtel Dieu
- Pôle digestif
- More details
-
- Search for mutations in SOD1 (superoxide dismutase 1) gene and TDP-43 (TAR-Binding Protein 43) gene in amyotrophic lateral sclerosis
- CHRU de Tours - Hôpital Bretonneau
- Service de Neurologie
- More details
-
- Search for genetic susceptibility factors in sporadic amyotrophic lateral sclerosis (quantitation of SMN1 and SMN2 genes)
- Faculté de médecine de Tours
- Département Imagerie et Cerveau
- More details
-
- FRANCE
- ILE-DE-FRANCE
- EVRY
- NMD-CHIP: design, production and technical validation of candidate genes targeted chips (WP3)
- Généthon
- Généthon - Banque d'ADN et de cellules
- More details
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- Study of the interactions between microglial cells, macrophages and neurons from three axes in an animal model of amyotrophic lateral sclerosis
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière
- More details
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FD)
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Département de génétique et cytogénétique
- More details
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- Clinical research on motoneuron diseases: pronostic and risk factors
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Fédération des maladies du système nerveux
- More details
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- Study of environmental, lifestyle, medical, family history, and genetic risk factors involved in amyotrophic lateral sclerosis in a homogeneous population (Quebec) and an diverse population (France)
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Fédération des maladies du système nerveux
- More details
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- Involvement of metabolic dysfunctions in the pathogenesis of amyotrophic lateral sclerosis
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Fédération des maladies du système nerveux
- More details
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- Localisation and identification of causative genes for amyotrohic lateral sclerosis
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Institut du Cerveau et de la Moëlle épinière
- More details
-
- FRANCE
- LANGUEDOC-ROUSSILLON
- MONTPELLIER
- Genetic study of sporadic and familial forms of ALS
- CHU de Montpellier - Hôpital Gui de Chauliac
- Service de Neurologie
- More details
-
- FRANCE
- LANGUEDOC-ROUSSILLON
- MONTPELLIER
- Amyotrophic lateral sclerosis epidemiology: risk factors, clumping cases
- CHU de Montpellier - Hôpital Gui de Chauliac
- Service de Neurologie
- More details
-
- FRANCE
- LANGUEDOC-ROUSSILLON
- MONTPELLIER
- Etiopathogenetic factors in amyotrophic lateral sclerosis: role of hypoxemia
- CHU de Montpellier - Hôpital Gui de Chauliac
- Service de Neurologie
- More details
-
- FRANCE
- LANGUEDOC-ROUSSILLON
- MONTPELLIER
- Natural history study of amyotrpohic lateral sclerosis: evolutive evaluation, electrophysiology role
- CHU de Montpellier - Hôpital Gui de Chauliac
- Service de Neurologie
- More details
-
- Nutritional critera during Amyotrophic Lateral Sclerosis (ALS)
- CHU de Limoges - Hôpital Dupuytren
- Unité de nutrition
- More details
-
- EURALS: epidemiology of amyotrophic lateral sclerosis : role of pronostic factors
- Faculté de médecine de Limoges
- Institut d'épidémiologie neurologique et de neurologie tropicale
- More details
-
- FRANCE
- NORD-PAS-DE-CALAIS
- LILLE
- Potential role for nocturnal PtcCO2 monitoring in the close follow up of amyotrophic lateral sclerosis patients
- CHRU de Lille
- Service de Pneumologie et Immuno-allergologie
- More details
-
- FRANCE
- PROVENCE-ALPES-COTE D'AZUR
- MARSEILLE
- NMD-CHIP: chip design, synthesis and technical validation for known genes involved in neuromuscular diseases (WP2)
- CHU de Marseille - Hôpital de la Timone
- Laboratoire de génétique moléculaire
- More details
-
- FRANCE
- PROVENCE-ALPES-COTE D'AZUR
- MARSEILLE
- Innovative gene therapy approach to deliver molecular inhibitors of neuronal death pathways to motor neurons of the spinal cord and brain of amyotrophic lateral sclerosis mouse models
- Parc scientifique et technologiques de Luminy
- Institut de Neurobiologie de la Méditerranée
- More details
-
- FRANCE
- PROVENCE-ALPES-COTE D'AZUR
- MARSEILLE
- MITOTARGET: mitochondrial apoptotic pathways in neurodegenerative diseases and assessment of the effects of new small molecules (WP4)
- Parc scientifique et technologiques de Luminy
- Institut de Biologie du Développement de Marseille-Luminy
- More details
-
- FRANCE
- PROVENCE-ALPES-COTE D'AZUR
- MARSEILLE
- MITOTARGET: dysfonction mitochondriale dans les maladies neurodégénératives: vers de nouvelles thérapies (coordination)
- Parc scientifique et technologiques de Luminy
- TROPHOS SA
- More details
-
- FRANCE
- PROVENCE-ALPES-COTE D'AZUR
- NICE
- Clinical research in amyotrophic lateral sclerosis patients
- Faculté de médecine de Nice Sophia-Antipolis
- Cellules souches et différenciation
- More details
-
- Enterovirus role in amyotrophic lateral sclerosis
- CHU de Lyon-GH Est - Hospices Civils de Lyon
- Laboratoire de virologie
- More details
-
- FRANCE
- RHONE-ALPES
- GRENOBLE
- First study in France searching a link between Amyotrophic Lateral Sclerosis (ALS) and beta-N-methylamino-L-alanine (BMAA) cyanotoxin
- CHU de Grenoble site Nord - Hôpital Albert Michallon
- Consultation du centre de référence des maladies neuromusculaires rares
- More details
-
- GERMANY
- Baden-Württemberg
- TÜBINGEN
- Cell Biology of the FTD/ALS Associated Nuclear Splice Factor TDP-43
- Hertie-Institut für klinische Hirnforschung
- Laboratorium für funktionelle Neurogenetik
- More details
-
- GERMANY
- Baden-Württemberg
- TÜBINGEN
- MITOTARGET: in vivo evidence of mitochondrial-targeted therapeutics (WP5)
- Universitätsklinikum Tübingen
- Medizinische Genetik Tübingen
- More details
-
- GERMANY
- Baden-Württemberg
- ULM
- Role of PGC-1A in the evolution of amyotrophic lateral sclerosis and effects of its regulation
- Universitätsklinikum Ulm
- Klinik für Neurologie
- More details
-
- GERMANY
- Baden-Württemberg
- ULM
- Epidemiology of motoneuron diseases - A case-control study
- Universitätsklinikum Ulm
- Klinik für Neurologie
- More details
-
- BNE: BrainNet Europe II: European brain tissue bank - Network for clinical neuroscience and basic research (coordination)
- Ludwig-Maximilians-Universität München
- Zentrum für Neuropathologie und Prionforschung
- More details
-
- NMD-CHIP: Chip validation and quality assessment (WP5)
- Universität Würzburg
- Institut für Humangenetik
- More details
-
- GERMANY
- Hessen
- FRANKFURT AM MAIN
- MITOTARGET: Mitochondriale Membran-Eigenschaften im Prozess der Neurodegeneration und Untersuchung der Effekte von neuen kleinen Molekülen (WP2)
- Johann Wolfgang Goethe-Universität Frankfurt
- Pharmakologisches Institut für Naturwissenschaftler
- More details
-
- ALS-degeneration: The molecular basis for neurodegeneration and muscle atrophy in ALS
- Tel Aviv University
- Dept. of Physiology and Pharmacology
- More details
-
- Sod1-linked familial amyotrophic lateral sclerosis: novel strategies to rescue mitochondrial damage in motor neurons
- Centro Europeo di Ricerca sul Cervello
- Laboratorio di Neurochimica
- More details
-
- Study of the function of mitochondria in mouse models of familial amyotrophic lateral sclerosis associated with the mutations in the SOD1 gene through genetic manipulation of the P66SHC molecular pathway
- Centro Europeo di Ricerca sul Cervello
- Laboratorio di Neurochimica
- More details
-
- Proposal for an integrated approach to rare diseases: a study between basic laboratory models and clinical epidemiology in amyotrophic lateral sclerosis (ALS)
- ISS - Istituto Superiore di Sanità
- Reparto Farmaci per la Salute del Bambino e della Donna - Dipartimento del Farmaco
- More details
-
- Role of IGF-1 on muscle regeneration and neuromuscular disorders
- Sapienza Università di Roma
- Dipartimento di Istologia ed Embriologia Medica
- More details
-
- ITALY
- LOMBARDIA
- CUSANO MILANINO
- A genome wide non-synonymous SNP scan of Amyotrophic Lateral Sclerosis
- Istituto Auxologico Italiano
- Laboratorio di Biologia Molecolare
- More details
-
- Mechanism of transmembrane integration of tail-anchored proteins into the endopasmic reticulum: characterization of a novel mechanism of membrane biogenesis and its implications for er physiology and pathology
- Consiglio Nazionale delle Ricerche
- Istituto di Neuroscienze
- More details
-
- Trauma and risk of amyotrophic lateral sclerosis
- Istituto di Ricerche Farmacologiche "Mario Negri"
- Laboratorio di Malattie Neurologiche
- More details
-
- Preclinical studies aimed to develop target genes based therapies for the treatment of amyotrophic lateral sclerosis
- Istituto di Ricerche Farmacologiche "Mario Negri"
- Laboratorio di Neurobiologia Molecolare
- More details
-
- In vitro and in vivo studies on the interplay between inflammatory and excitotoxic mechanisms and on the role of p38 mitogen activated protein kinase pathway in the pathogenesis of familial amyotrophic lateral sclerosis
- Istituto di Ricerche Farmacologiche "Mario Negri"
- Dipartimento di Neuroscienze
- More details
-
- Novel biomarkers of amyotrophic lateral sclerosis: role in pathogenesis and possible therapeutic targets
- Istituto di Ricerche Farmacologiche "Mario Negri"
- Laboratorio di Proteomica Traslazionale
- More details
-
- Novel biomarkers of amyotrophic lateral sclerosis: role in pathogenesis and possible therapeutic targets
- Istituto di Ricerche Farmacologiche "Mario Negri"
- Laboratorio di Proteomica Traslazionale
- More details
-
- Role of altered proteolysis in the degeneration of motor neurons in in vivo and in vitro models of Amyothrophic lateral sclerosis
- Università degli Studi di Milano
- Dipartimento di Scienze Biomolecolari e Biotecnologie
- More details
-
- Apoptosis of spinal cord astrocytes secondary to ALS-Linked SOD1 mutations: mechanism, relevance for motor neuron degeneration and protective pharmacological intervention.
- IRCCS Fondazione Salvatore Maugeri
- Laboratorio di Ricerca sulle malattie Neurodegenerative
- More details
-
- ITALY
- LOMBARDIA
- SAN DONATO MILANESE
- Validation of a neuromuscular individualized quality of life measure in Italy
- IRCCS Policlinico San Donato
- Clinica Neurologica - Centro per lo Studio delle Malattie Neuromuscolari
- More details
-
- Amyotrophic lateral sclerosis (SLA) and riboflavin responsive multiple Acyl-CoA dehydrogenase deficiency (RR-MADD)
- Università degli Studi di Bari
- Laboratorio di Biochimica e Biologia Molecolare E.Quagliarello
- More details
-
- Biological and genetic variables in the pathogenesis and clinical progression of amyotrophic lateral sclerosis: identification of biomarkers
- Consiglio Nazionale delle Ricerche
- Laboratorio di Neuroscienze
- More details
-
- Functional study of the Senataxin gene in Drosophila, responsible of motoneuron disease
- IRCCS "E. Medea" - Polo Regionale di Conegliano
- Associazione ''La Nostra Famiglia''
- More details
-
- Development of motoneuron disease models in Drosophila
- IRCCS "E. Medea" - Polo Regionale di Conegliano
- Associazione ''La Nostra Famiglia''
- More details
-
- Modelling the role of Atlastin in physiology and moton neuron pathology
- Università degli Studi di Padova
- Dipartimento di Farmacologia
- More details
-
- Gene expression and motoneuron death in familial amyotrophic lateral sclerosis
- Università degli Studi di Verona
- Laboratorio di Neuromorfologia Dipartimento di Scienze Morfologico-Biomediche
- More details
-
- NETHERLANDS
- Gelderland
- NIJMEGEN
- Saliva loss in ALS
- UMC St Radboud - Oost
- Afdeling Revalidatie
- More details
-
- NETHERLANDS
- Gelderland
- NIJMEGEN
- McArm study: development of a motion controlled arm support
- UMC St Radboud - Oost
- Afdeling Revalidatie
- More details
-
- NETHERLANDS
- Gelderland
- NIJMEGEN
- Ultrasound muscle research in ALS patients
- UMC St Radboud - Universitair Medisch Centrum St Radboud
- Afdeling Neurologie
- More details
-
- NETHERLANDS
- Noord-Holland
- AMSTERDAM
- Cognitive disturbances in motor neuron diseases: COMO study
- AMC - Academisch Medisch Centrum
- Afdeling Neurologie
- More details
-
- NETHERLANDS
- Noord-Holland
- AMSTERDAM
- Liquor analysis in motor neuron diseases: LIMA study
- AMC - Academisch Medisch Centrum
- Afdeling Neurologie
- More details
-
- NETHERLANDS
- Noord-Holland
- AMSTERDAM
- ALS case-management: The effectiveness of intensive case management in patients with Amyotrophic Lateral Sclerosis (ALS) and their caregivers
- AMC - Academisch Medisch Centrum
- Afdeling Revalidatie
- More details
-
- NETHERLANDS
- Noord-Holland
- AMSTERDAM
- Symptoms of central motoneurons in early-stage ALS
- BovenIJ Ziekenhuis
- Afdeling Neurologie
- More details
-
- NETHERLANDS
- Utrecht
- UTRECHT
- FACTS-2-ALS: Quality of Life and Rehabilitation Care in Amyotrophic Lateral Sclerosis (ALS)
- Revalidatiecentrum De Hoogstraat
- More details
-
- NETHERLANDS
- Utrecht
- UTRECHT
- PYRAMID: Phenotype Research for ALS modifyer discovery
- Rudolf Magnus Institute Stratenum
- Neuromuscular Disorders Group
- More details
-
- NETHERLANDS
- Utrecht
- UTRECHT
- FACTS-2-ALS: Quality of Life and Rehabilitation Care in Amyotrophic Lateral Sclerosis (ALS)
- UMC Utrecht - Universitair Medisch Centrum Utrecht
- Afdeling Revalidatie en Sportgeneeskunde
- More details
-
- NETHERLANDS
- Utrecht
- UTRECHT
- ALS case-management: The effectiveness of intensive case management in patients with Amyotrophic Lateral Sclerosis (ALS) and their caregivers
- UMC Utrecht - Universitair Medisch Centrum Utrecht
- Polikliniek Neurologie en Neurochirurgie
- More details
-
- Gene polymorphism (C2578A, G1154A, G634C) of vascular endothelial growth factor and sporadic form of amyotrophic lateral sclerosis
- CM UJ Jagiellonian University Medical College
- Klinika Neurologii - Department of neurology
- More details
-
- Gene polymorphism (C2578A, G1154A, G634C) of vascular endothelial growth factor and sporadic form of amyotrophic lateral sclerosis
- Polish Ministry of Science and Higher Education
- More details
-
- Kinesins participation in amyotrophic lateral sclerosis pathogenesis.
- Warszawski Uniwersytet Medyczny - Medical University of Warsaw
- Klinika Neurologii - Department of Neurology
- More details
-
- Crosstalk between neurotrophic factor receptors (TrkB) and adenosine A2A receptors: implications for Amyotrophic Lateral Sclerosis (ALS).
- Faculdade de Medicina da Universidade de Lisboa
- Unidade de Neurociências
- More details
-
- Respiratory Rehabilitation in Amyotrophic Lateral Sclerosis: clinical and biochemical impact.
- Faculdade de Medicina da Universidade de Lisboa
- Unidade de Neuromusculares
- More details
-
- Crosstalk between neurotrophic factor receptors (TrkB) and adenosine A2A receptors: implications for Amyotrophic Lateral Sclerosis (ALS).
- Fundação para Ciência e a Tecnologia
- More details
-
- Mechanisms of SOD1 toxic aggregation in neurodegenerative processes
- Instituto de Tecnologia Química e Biológica
- Protein Biochemistry Folding and Stability
- More details
-
- Discovery and development of new drugs for Amyotrophic lateral sclerosis
- Parque Tecnológico de Ciencias de la Salud
- Fundación Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía
- More details
-
- Development of gene therapy vectors in amyotrophic lateral sclerosis animal models: use of tetanic toxin fragment C and neurotrophic factors
- Universidad de Zaragoza. Facultad de Veterinaria
- Laboratorio de Genética Bioquímica
- More details
-
- Functional genomic study in skeletal muscle of ALS transgenic model and its modification after of neurotrophic factors application
- Universidad de Zaragoza. Facultad de Veterinaria
- Laboratorio de Genética Bioquímica
- More details
-
- Relationship Between Respiratory Functional Tests and Image Thoracic Techniques in Patients With Neuromuscular Diseases [Amyotrophic Lateral Sclerosis]
- Hospital de la Santa Creu i Sant Pau
- Servicio de Neumología
- More details
-
- SPAIN
- Cataluña
- L'HOSPITALET DE LLOBREGAT
- Neuronal communication and neuromuscular degenerative diseases: X-linked Charcot-Marie-Tooth disease (CMTX) and Amyotrophic Lateral Sclerosis (ALS)
- IDIBELL - Instituto de Investigación Biomédica de Bellvitge
- Neurobiología Celular y Molecular
- More details
-
- Oxidative proteic modifications and proteolysis in the amyotrophic lateral sclerosis physiopathology
- Universitat de Lleida. Campus de Ciències de la Salut
- Departamento de Medicina Experimental
- More details
-
- Validation of a quantitative clinical neuromuscular evaluation system for application in clinical trials in patients with amyotrophic lateral sclerosis and other progressive disabling motor disorders
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- More details
-
- Study of quality of life in patients with ALS (amyotrophic lateral sclerosis) and their involvement in resources and multidisciplinary support services
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- More details
-
- Study of the status of health and social care for people with ALS (amyotrophic lateral sclerosis) in Spain
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- More details
-
- Pilot project for determining levels of different potential biomarkers in plasma and peripheral blood mononuclear cells in patients with amyotrophic lateral sclerosis
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- More details
-
- Study of mitochondrial function in mice model of amyotrophic lateral sclerosis (ALS). Genomic and proteomic study of fibroblasts and muscle from patients with ALS
- Hospital Universitario 12 de Octubre
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- More details
-
- Discovery and development of new drugs for Amyotrophic lateral sclerosis
- Instituto de Química Médica (CSIC)
- Neurofármacos
- More details
-
- New effective drugs for amyotrophic lateral sclerosis
- Instituto de Química Médica (CSIC)
- Neurofármacos
- More details
-
- Discovery and development of new drugs for Amyotrophic lateral sclerosis
- Universidad Complutense de Madrid. Facultad de Ciencias Biológicas
- Departamento de Biología Celular
- More details
-
- Potential of cannabinoids as neuroprotective agents in neurodegenerative disorders: Huntington disease, amyotrophic lateral sclerosis and spinocerebellar ataxia, types 2 and 3
- Universidad Complutense de Madrid. Facultad de Medicina
- Grupo de Neuroquímica de los Cannabinoides
- More details
-
- Mitochondrial alterations in fibroblasts from patients with amyotrophic lateral sclerosis. The role of mitochondrial DNA haplogroup in the development of the disease
- Instituto de Salud Carlos III-Campus de Majadahonda
- Unidad de Investigación Biomédica
- More details
-
- SWEDEN
- Stockholms läns landsting
- STOCKHOLM
- In vitro molecular mechanism of amyotrophic lateral sclerosis
- Stockholm University
- Department of Biochemistry and Biophysics
- More details
-
- SWEDEN
- Västerbottens läns landsting
- UMEÅ
- Disease mechanisms in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
- Umeå University
- Department of Medical Biosciences
- More details
-
- SWEDEN
- Västerbottens läns landsting
- UMEÅ
- Studies of misfolded SOD1 in amyotrophic lateral sclerosis (ALS)
- Umeå University
- Department of Medical Biosciences
- More details
-
- SWEDEN
- Västerbottens läns landsting
- UMEÅ
- Molecular portfolio of the extraocular muscles: clues to protection in muscular disease
- Umeå University Hospital
- Department of Clinical Sciences
- More details
-
- SWEDEN
- Västerbottens läns landsting
- UMEÅ
- Genetic factors causing sporadic and familial amyotrophic lateral sclerosis (ALS/MND) with or without dementia
- Umeå University Hospital
- Department of Pharmacology and Clinical Neuroscience
- More details
-
- SWITZERLAND
- Suisse Romande
- GENÈVE
- Studies on the prevention of motoneuron cell death
- Centre Médical Universitaire - CMU
- Department of Basic Neuroscience
- More details
-
- SWITZERLAND
- Suisse Romande
- LAUSANNE
- Innovative gene therapy approach to deliver molecular inhibitors of neuronal death pathways to motor neurons of the spinal cord and brain of amyotrophic lateral sclerosis mouse models
- EPFL - Ecole Polytechnique Fédérale de Lausanne
- Sciences de la Vie
- More details
-
- UNITED KINGDOM
- Greater London
- LONDON
- Explaining and changing adverse illness perceptions in muscle disease by a cognitive behavioural therapy technique
- Guy's Hospital
- Health Psychology Section, Psychology Department, Institute of Psychiatry
- More details
-
- UNITED KINGDOM
- Greater London
- LONDON
- Development of a diagnostic test for familial amyotrophic lateral sclerosis type 6 through mutation screening in FUS gene
- National Hospital for Neurology and Neurosurgery
- The MRC Centre for Neuromuscular Disease
- More details
-
- UNITED KINGDOM
- Greater London
- LONDON
- Study the role of TDP43, a new gene mutation identified recently for amyotrophic lateral sclerosis in motor neurons
- UCL Institute of Neurology
- Department of Neurodegenerative Disease
- More details
-
- UNITED KINGDOM
- South Yorkshire
- SHEFFIELD
- MITOTARGET: mitochondrial metabolic function and oxidative stress in neurodegenerative diseases and assessment of the effects of new small molecules (WP3)
- The Medical School - University of Sheffield
- Academic Neurology Unit
- More details
-
- UNITED KINGDOM
- South Yorkshire
- SHEFFIELD
- MITOTARGET: mitochondrial dynamics in neurodegenerative diseases and assessment of the effects of new small molecules (WP1)
- The University of Sheffield
- Department of Neuroscience
- More details
-
- UNITED KINGDOM
- Tyne & Wear
- NEWCASTLE UPON TYNE
- TREAT-NMD: Accelerating Treatments for Neuromuscular Diseases (coordination)
- International Centre for Life
- Institute of Genetic Medicine
- More details
-
- UNITED KINGDOM
- Tyne & Wear
- NEWCASTLE UPON TYNE
- NMD-CHIP: societal aspects of the development of targeted DNA-chips for high throughput diagnosis of neuromuscular disorders (WP7)
- Newcastle University
- Policy, Ethics and Life Sciences Research Centre
- More details
